Correlation Between Bio Path and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bio Path and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Bio Path and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Pieris Pharmaceuticals.
Diversification Opportunities for Bio Path and Pieris Pharmaceuticals
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Bio and Pieris is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Bio Path i.e., Bio Path and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bio Path and Pieris Pharmaceuticals
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Pieris Pharmaceuticals. In addition to that, Bio Path is 2.57 times more volatile than Pieris Pharmaceuticals. It trades about -0.16 of its total potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest 1,610 in Pieris Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of 50.00 from holding Pieris Pharmaceuticals or generate 3.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Bio Path Holdings |
| Pieris Pharmaceuticals |
Bio Path and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Pieris Pharmaceuticals
The main advantage of trading using opposite Bio Path and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |